Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.200
+0.040 (3.45%)
At close: May 12, 2025, 4:00 PM
1.220
+0.020 (1.67%)
After-hours: May 12, 2025, 6:56 PM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $37.63 million as of May 12, 2025. Its market cap has decreased by -87.17% in one year.
Market Cap
37.63M
Enterprise Value
-139.46M
1-Year Change
-87.17%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $37.63M, a decrease of -84.00%. That is a compound annual growth rate of -52.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 36.37M | -80.60% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |